Association between peritoneal dialysate effluent leukocytosis and amlodipine besylate.
American Journal of Kidney Diseases(2009)
摘要
Dialysate effluent leukocytosis is consistent with a greater degree of infection or inflammation in patients receiving peritoneal dialysis. This study describes a girl aged 2 years 9 months with end-stage renal disease resulting from crescent glomerulonephritis and severe interstitial nephritis who developed leukocytosis with a predominance of lymphocytes in the dialysate effluent, and in whom the effluent cell count normalized 1 week after discontinuation of amlodipine besylate therapy. Rechallenge confirmed that amlodipine was the offending agent causing effluent leukocytosis. Am J Kidney Dis 53:e1-e3. (C) 2009 by the National Kidney Foundation, Inc.
更多查看译文
关键词
Peritoneal dialysis,dialysate effluent leukocytosis,calcium channel blocker,amlodipine besylate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络